LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹0.70 Cr | ₹-1.88 Cr | ₹-4.50 Cr | ₹-0.70 Cr | ₹6.77 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹0.70 Cr |
Mar2023 | ₹-1.88 Cr |
Mar2022 | ₹-4.50 Cr |
Mar2021 | ₹-0.70 Cr |
Mar2020 | ₹6.77 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹0.70 Cr | Positive | |
Mar2023 | ₹-1.88 Cr | Negative | |
Mar2022 | ₹-4.50 Cr | Negative | |
Mar2021 | ₹-0.70 Cr | Negative | |
Mar2020 | ₹6.77 Cr | - |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,141.3 Cr | -3.4% | -5.6% | -7.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.4% |
-5.6% |
-7.8% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses